194 related articles for article (PubMed ID: 3929190)
1. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
Hirata Y; Nagatsu T
Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
[TBL] [Abstract][Full Text] [Related]
2. The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices.
Hirata Y; Sugimura H; Takei H; Nagatsu T
Brain Res; 1986 Nov; 397(2):341-4. PubMed ID: 3099974
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Hirata Y; Nagatsu T
Brain Res; 1985 Jun; 337(1):193-6. PubMed ID: 2860954
[TBL] [Abstract][Full Text] [Related]
4. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
5. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
Vyas I; Heikkila RE; Nicklas WJ
J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
[TBL] [Abstract][Full Text] [Related]
6. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
Kinemuchi H; Arai Y; Toyoshima Y
Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
Nagatsu T; Hirata Y
Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
[TBL] [Abstract][Full Text] [Related]
8. Early and late effects of systemically administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase activity in vitro and on tyrosine hydroxylation in tissue slices of mouse striatum.
Hirata Y; Nagatsu T
Neurosci Lett; 1986 Jul; 68(2):245-8. PubMed ID: 2875421
[TBL] [Abstract][Full Text] [Related]
9. MPTP, MPP+ and mitochondrial function.
Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE
Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its metabolite 1-methyl-4-phenylpyridine on acetylcholine synthesis in synaptosomes from rat forebrain.
Cheeseman AJ; Clark JB
J Neurochem; 1987 Apr; 48(4):1209-14. PubMed ID: 3102694
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice.
Lee EH
Neurosci Lett; 1988 Jun; 88(3):297-302. PubMed ID: 3260360
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
Chang GD; Ramirez VD
Brain Res; 1986 Mar; 368(1):134-40. PubMed ID: 3485463
[TBL] [Abstract][Full Text] [Related]
13. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
[TBL] [Abstract][Full Text] [Related]
14. Acute peripheral catecholaminergic changes in rat after MPTP and MPP+ treatment.
Ambrosio S; Mahy N
Rev Esp Fisiol; 1989 Jun; 45(2):157-61. PubMed ID: 2570448
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+).
Ozaki N; Nakahara D; Mogi M; Harada M; Kiuchi K; Kaneda N; Miura Y; Kasahara Y; Nagatsu T
Neurosci Lett; 1988 Feb; 85(2):228-32. PubMed ID: 2897647
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a rat pheochromocytoma cell line, PC12h.
Naoi M; Takahashi T; Nagatsu T
Life Sci; 1987 Dec; 41(24):2655-61. PubMed ID: 3121966
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
19. MPTP causes a non-reversible depression of synaptic transmission in mouse neostriatal brain slice.
Wilson JA; Wilson JS; Weight FF
Brain Res; 1986 Mar; 368(2):357-60. PubMed ID: 3008929
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium.
Kass GE; Wright JM; Nicotera P; Orrenius S
Arch Biochem Biophys; 1988 Feb; 260(2):789-97. PubMed ID: 2963592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
